These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 29968030)
41. TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America. Valente SA; Tendulkar RD; Cherian S; Shah C; Ross DL; Lottich SC; Laronga C; Broman KK; Donnelly ED; Bethke KP; Shaw C; Lockney NA; Pederson A; Rudolph R; Hasselle M; Kelemen P; Hermanto U; Ashikari A; Kang S; Hoefer RA; McCready D; Fyles A; Escallon J; Rohatgi N; Graves J; Graves G; Willey SC; Tousimis E; Riley L; Deb N; Tu C; Small W; Grobmyer SR Ann Surg Oncol; 2021 May; 28(5):2512-2521. PubMed ID: 33433786 [TBL] [Abstract][Full Text] [Related]
42. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related]
43. Clinical analysis of intraoperative radiotherapy during breast-conserving surgery of early breast cancer in the Chinese Han population. Wang X; Liu J; Wang W; Feng Q; Wang X Oncotarget; 2015 Dec; 6(40):43120-6. PubMed ID: 26517686 [TBL] [Abstract][Full Text] [Related]
44. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848 [TBL] [Abstract][Full Text] [Related]
45. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy. Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093 [TBL] [Abstract][Full Text] [Related]
46. ABC of breast diseases: breast cancer. Sainsbury JR; Anderson TJ; Morgan DA BMJ; 2000 Sep; 321(7263):745-50. PubMed ID: 10999911 [No Abstract] [Full Text] [Related]
47. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
48. Fat necrosis and parenchymal scarring after breast-conserving surgery and radiotherapy with an intraoperative electron or fractionated, percutaneous boost: a retrospective comparison. Piroth MD; Fischedick K; Wein B; Heindrichs U; Piroth DM; Holy R; Pinkawa M; Eble MJ Breast Cancer; 2014 Jul; 21(4):409-14. PubMed ID: 23073742 [TBL] [Abstract][Full Text] [Related]
49. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results]. Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486 [TBL] [Abstract][Full Text] [Related]
50. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation. Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508 [TBL] [Abstract][Full Text] [Related]
51. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases. Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897 [TBL] [Abstract][Full Text] [Related]
52. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
53. Risk Factors Leading to Complications in Early-Stage Breast Cancer Following Breast-Conserving Surgery and Intraoperative Radiotherapy. Rakhra S; Bethke K; Strauss J; Hayes JP; Hansen N; Khan SA; Helenowski I; Donnelly ED Ann Surg Oncol; 2017 May; 24(5):1258-1261. PubMed ID: 27853900 [TBL] [Abstract][Full Text] [Related]
54. Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment. Kim JW; Cho Y; Choi J; Ahn SG; Jeong J; Lee IJ Ann Surg Oncol; 2019 Dec; 26(13):4294-4301. PubMed ID: 31520209 [TBL] [Abstract][Full Text] [Related]
55. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases. Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041 [TBL] [Abstract][Full Text] [Related]
56. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. Pinsky RW; Rebner M; Pierce LJ; Ben-David MA; Vicini F; Hunt KA; Helvie MA AJR Am J Roentgenol; 2007 Jul; 189(1):140-4. PubMed ID: 17579163 [TBL] [Abstract][Full Text] [Related]
57. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT. Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D Ann Surg Oncol; 2014 Nov; 21(12):3793-9. PubMed ID: 25138079 [TBL] [Abstract][Full Text] [Related]
58. Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT. Silverstein MJ; Fastner G; Maluta S; Reitsamer R; Goer DA; Vicini F; Wazer D Ann Surg Oncol; 2014 Nov; 21(12):3787-92. PubMed ID: 25160734 [TBL] [Abstract][Full Text] [Related]
59. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome. Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241 [TBL] [Abstract][Full Text] [Related]
60. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M; Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]